SCHEMBL21775722

SCHEMBL21775722

COc1c(C)nc2cc(-c3ccc(Cl)cc3)nn2c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.57
RAB9A P51151 6/20 0.57
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
ATM Q13315 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 4/20 0.49
HPGD P15428 4/20 0.49
ALDH1A1 P00352 3/20 0.49
PKM P14618 1/20 0.49
CDK5 Q00535 1/20 0.49
CDK5R1 Q15078 1/20 0.49
MAPT P10636 4/20 0.48
TP53 P04637 5/20 0.48
DPP4 P27487 2/20 0.47
DPP8 Q6V1X1 2/20 0.47
DPP9 Q86TI2 1/20 0.47
RXFP1 Q9HBX9 1/20 0.45
THRB P10828 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775473 0.86 NPC1 (0.53) NPC1RAB9AKMT2AMEN1ATM
SCHEMBL21775736 0.86 NPC1 (0.53) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL21775742 0.84 MEN1 (0.47) NPC1RAB9AKMT2AMEN1ATM
SCHEMBL21775737 0.83 NPC1 (0.62) NPC1RAB9AKMT2AMEN1ATM
SCHEMBL21775735 0.79 NPC1 (0.51) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL21775454 0.79 NPC1 (0.57) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL21749178 0.79 NPC1 (0.57) NPC1RAB9AKMT2AMEN1ATM
SCHEMBL21749203 0.79 NPC1 (0.57) NPC1RAB9AKMT2AMEN1ATM
SCHEMBL21775509 0.79 NPC1 (0.57) NPC1RAB9AKMT2AMEN1ATM
SCHEMBL21774071 0.78 NPC1 (0.56) NPC1RAB9AKMT2AMEN1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 NPC1 1179/4885RAB9A 988/4885KMT2A 3817/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 NPC1 1179/4885RAB9A 988/4885KMT2A 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.